Business Wire

REPLY

Share
Reply Shapes the Future of Autonomous Mobile Robots with the Power of Microsoft Azure

Reply announced today that it has developed an end-to-end solution architecture for autonomous mobile robots (AMR) on Microsoft Azure that enables new business applications across industries, reduces upfront costs and allows for the rapid implementation of customer-specific robotics use cases.

The solution combines Microsoft Azure services, the agility of Boston Dynamics' SPOT and Reply’s knowledge of intelligent cloud computing services, edge computing and artificial intelligence. To demonstrate the capabilities of a scalable and versatile robotics platform, Reply implemented an automated vehicle-damage-detection solution for rental or leasing companies that leverages this architecture. In fact, rental or leasing companies must inspect vehicles for any damage after they are returned in order to ensure the safety and quality of their fleet for their customers. This is usually done in the time- and cost-consuming manual process of walking around the car, visually inspecting it, assessing the severity of the damage and conducting a damage report.

Reply integrates Azure Cognitive Services, Machine Learning and DevOps as well as Power Apps and Power BI. Thanks to Azure's intelligent service foundation, agile workflows and machine learning, this process can be fully automated. Using computer vision, SPOT moves freely through the parking area and scans the license plates to find the right vehicle. Once detected, it walks around the vehicle to record its condition by continuously collecting visual data with its camera and sensors. This information is processed “on the edge” or transmitted to the cloud, where advanced image recognition and machine leaning algorithms perform the damage detection. All detected damages are saved in the return protocol, and they can be presented to the customer and the fleet manager for approval.

“This platform sets the power of Microsoft Azure on the move by bringing it from the Cloud to the Edge and into highly advanced mobile robotic devices, giving them the autonomy to unlock novel business use cases. Thanks to the agile reference architecture, we are able to implement customer-specific use cases in various industries that include all types of mobile robots or drones ”, comments Filippo Rizzante, CTO Reply.

“Reply is a long-term, trusted partner in delivering Azure IoT solutions, and we’re delighted to continue our collaboration on this new scalable robotics offering. By leveraging Microsoft Azure, we can help accelerate this transformation by making it easier for businesses to bring AI and analytics capabilities to these autonomous systems in a consistent and secure way,” adds Lakecia Gunter, Vice President and GM, Global IOT Channel at Microsoft.

With their agility, autonomous mobile robots (AMR) are able to move independently from a central infrastructure on terrain that is not traditionally designed for robots. They can be used in hazardous environments and environments, that are harmful to people. According to ResearchAndMarkets.com, the global market for automated guided vehicle (AGV) and AMR is expected to reach $13.2 Billion by 2026 with a growth rate of around 35%. Both AGVs and AMRs collectively are going to cross the installed base of 1.5 Million in the next 5 years to make mobile robots a new normal in our day-to-day operational activities.

Reply

Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com

Source Global Mobile Robots (AGV & AMR) Market:

https://www.businesswire.com/news/home/20210115005190/en/Global-Mobile-Robots-AGV-AMR-Market-Expected-to-Reach-14B-by-2026---The-New-Normal-in-Our-Day-to-Day-Operational-Activities---ResearchAndMarkets.com

Link:

ClickThru

Social Media:

https://www.facebook.com/ReplyinUK/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 18:22:00 CEST | Press release

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct

Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 17:45:00 CEST | Press release

Celltrion’s Omlyclo™, the first and only omalizumab biosimilar in Europe, will be commercially available starting in Norway, with subsequent rollouts in European countries Results from the global Phase III clinical trial of Omlyclo™ (CT-P39) for the treatment of chronic spontaneous urticaria (CSU), allergic asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) will be presented at a satellite symposium during the 2025 European Academy of Dermatology and Venereology (EADV) Congress Celltrion highlights the strength of its expanding dermatology portfolio with positive clinical results for CT-P55, a biosimilar candidate referencing secukinumab With the launch of Omlyclo™, Celltrion underscores its commitment to advancing innovative and accessible treatments in immunology and dermatology Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereo

Andersen Consulting tilføjer samarbejdsfirmaet Charter18.9.2025 17:14:00 CEST | Pressemeddelelse

Andersen Consulting udvider sine digitale transformationskapaciteter gennem en samarbejdsaftale med Charter, et canadisk konsulentfirma, der er specialiseret i IT-strategi, managed services og applikationslevering. Charter blev grundlagt i 1997 og leverer teknologiprojekter med en forretningsorienteret tankegang og dyb teknisk ekspertise, herunder inden for IT-rådgivning, cloud-infrastruktur, cybersikkerhed, applikationsudvikling, projektlevering og forretningsarkitektur. Charter hjælper traditionelle virksomheder, offentlige institutioner, tjenesteudbydere og mellemstore kunder med implementering, netværksinfrastruktur og kundeorienterede applikationer – der leveres gennem en livscyklus-tilgang fra strategi til udførelse. "Vores mål hos Charter har altid været at fjerne kompleksiteten fra IT og hjælpe organisationer med at bevæge sig fremad med tillid," siger Kelly Michell, præsident for Charter. "Vores samarbejde med Andersen Consulting gør det muligt for os at bringe vores integrere

Andersen Consulting udvider sit udbud inden for cybersikkerhed og teknologi med tilføjelsen af Move18.9.2025 17:06:00 CEST | Pressemeddelelse

Andersen Consulting har indgået en samarbejdsaftale med Move, der er en førende virksomhed inden for it-infrastruktur, driftstjenester og digitale løsninger til virksomheder. Move befinder sig i Norge og Sverige. Move blev grundlagt i 1989 og leverer konsulentydelser, it-løsninger og driftstjenester. Virksomheden har ekspertise inden for cybersikkerhed, cloud-løsninger, server- og lagringsløsninger, netværkskommunikation og implementering af AI. Move samarbejder med mellemstore og store virksomheder om at designe, implementere og drive sikre, skalerbare og fremtidssikrede it-miljøer. "Dette samarbejde er en spændende mulighed for at skabe endnu større værdi for vores kunder," siger Roald Sannæs, der er administrerende direktør i Move. "Med vores kompetencer og Andersen Consultings globale rækkevidde og ekspertise kan vi levere mere helhedsorienterede løsninger, der hjælper organisationer med at løse nutidens udfordringer og forudse fremtidens muligheder." "Move har opbygget et godt ren

Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 16:40:00 CEST | Press release

The inaugural ranking by TIME, in partnership with Statista, features AMRA as one of the world’s leading health technology companies that are “driving innovation, enhancing accessibility, and contributing to a more effective and sustainable health care system” AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproduc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye